DHG Pharmaceutical JSC DHG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 17.79
- Price/Sales
- 2.96
- Dividend Yield (Trailing)
- 3.06%
- Dividend Yield (Forward)
- 3.06%
- Total Yield
- 3.08%
Company Profile
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotic, antifungal, and antiparasitic; analgesic and antipyretic; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 2,789
- Website
- https://www.dhgpharma.com.vn
Comparables
Valuation
|
Metric
|
DHG
|
BXPHARMA
|
1SKF401E
|
|---|---|---|---|
Price/Earnings (Normalized) | 17.79 | 11.26 | — |
Price/Book Value | 3.06 | 1.19 | — |
Price/Sales | 2.96 | 1.28 | — |
Price/Cash Flow | 16.08 | — | — |
Price/Earnings
DHG
BXPHARMA
1SKF401E
Financial Strength
|
Metric
|
DHG
|
BXPHARMA
|
1SKF401E
|
|---|---|---|---|
Quick Ratio | 2.52 | 0.70 | 5.90 |
Current Ratio | 3.90 | 1.80 | 5.90 |
Interest Coverage | 33.41 | 7.08 | — |
Quick Ratio
DHG
BXPHARMA
1SKF401E
Profitability
|
Metric
|
DHG
|
BXPHARMA
|
1SKF401E
|
|---|---|---|---|
Return on Assets (Normalized) | 15.23% | 7.64% | 11.93% |
Return on Equity (Normalized) | 19.03% | 11.97% | 14.50% |
Return on Invested Capital (Normalized) | 14.15% | 10.74% | 14.48% |
Return on Assets
DHG
BXPHARMA
1SKF401E
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Fqyzqpnd | Ggnq | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Mkddnfwc | Qdpzsq | $72.9 Bil | |
HLN
| Haleon PLC ADR | Tygvhkbdw | Lhxfh | $37.5 Bil | |
VTRS
| Viatris Inc | Rcqcbnj | Xflbt | $13.3 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hyjcshntc | Bxpxq | $11.7 Bil | |
CTLT
| Catalent Inc | Vlzxdbby | Pfbghr | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Sqqkjzbq | Jxkpb | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Zyftggfq | Sqld | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bqvfgdj | Psswj | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Fhyzqkgvk | Ggd | $3.0 Bil |